Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.01 AUD
Change Today 0.00 / 0.00%
Volume 270.0K
AGX On Other Exchanges
As of 1:34 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

agenix ltd (AGX) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/6/15 - A$0.02
52 Week Low
10/8/14 - A$0.01
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AGENIX LTD (AGX)

Related News

No related news articles were found.

agenix ltd (AGX) Related Businessweek News

No Related Businessweek News Found

agenix ltd (AGX) Details

Agenix Limited does not have significant operations. Previously, it was engaged in commercializing next generation drugs and diagnostics. The company is based in Melbourne, Australia.

agenix ltd (AGX) Top Compensated Officers

Chief Financial Officer and Company Secretary
Total Annual Compensation: A$105.0K
Manager of New Drug Development - Agenix Biop...
Total Annual Compensation: A$6.7K
Legal Advisor
Total Annual Compensation: A$34.1K
Compensation as of Fiscal Year 2015.

agenix ltd (AGX) Key Developments

Agenix Announces Executive Changes

Agenix Ltd. announced that Mr. Nicholas Weston has resigned as Executive Chairman and Director effective June 1, 2015. Mr. Weston will remain a Director of the Group’s wholly owned China subsidiary, Agenix Biopharmaceutical (Shanghai) Company Limited in order to complete the repatriation of funds from China previously announced. Mr. Weston will continue to assist the company as a trusted and respected legal advisor. Mr. Craig Chapman will act a Non-Executive Chairman. The company announced that Mr. Adam Gallagher has been appointed a Non-Executive Director of the Company and its Australian Subsidiaries. Mr. Gallagher is a Director of Scintilla Strategic Investments Limited, an ASX Microcap investment company. Scintilla is a major shareholder of the Company. Mr. Gallagher is a Director and Company Secretary of Pacific Environment Limited.

Agenix Ltd., Special/Extraordinary Shareholders Meeting, May 12, 2015

Agenix Ltd., Special/Extraordinary Shareholders Meeting, May 12, 2015. Agenda: To consider relation to a settlement of legal proceedings.

Agenix and OKS Settle Writ

Agenix Ltd. has agreed with OKS AGX Inc. to settle the Supreme Court proceedings commenced by OKS. As announced to the market on December 24, OKS commenced proceedings involving claims arising from a $5 million share subscription agreement entered into between Agenix and OKS in March 2008. It made no claims concerning the conduct of any current Agenix board member or personnel. Following discovery of the existence of the writ, which had been issued, but not served, Agenix determined that it was in the best interests of the company that the litigation be settled. The key components of the settlement transaction are as follows: Agenix to provide and maintain OKS with a 10% shareholding in the total issued capital of Agenix for a period of two years or until a point immediately preceding a merger or acquisition transaction by Agenix, whichever occurs first. OKS to be assigned all rights, title and interest in the Thromboview project.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGX:AU A$0.01 AUD 0.00

AGX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AGX.
View Industry Companies

Industry Analysis


Industry Average

Valuation AGX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 232.9x
Price/Book 2.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGENIX LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at